FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1716-1719 May 31, 2001 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: The DASH–Sodium Trial (Jan. 4 issue)¹ has demonstrated that a reduction in sodium intake over a period of 30 days lowers blood pressure. This finding is consistent with what more than 100 previous short-term, randomized trials have convincingly shown. What is remarkable — and disappointing, given this demanding and costly undertaking — is that the report was limited to the single selected favorable effect of salt on blood pressure, to the exclusion of other important physiological effects. For example, reducing the consumption of sodium also increases the plasma renin level by a factor of 3.6 and the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Freeman, D. A, Petitti, D. B (2002). Commentary: Salt, blood pressure and public policy. Int J Epidemiol 31: 319-320 [Full Text]